Carmell Therapeutics Up 48% On Merger With Axolotl Biologix

Shares of Carmell Therapeutics Corporation (CTCX) are up 48% on Thursday after the company announced its merger with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company.

Related Keywords

,Nasdaq ,Carmell Therapeutics Corporation ,Flagstaff Based Axolotl Biologix ,Initial Equity Value ,Milestone Equity Payments ,Axolotl Biologix ,